View More Recent Stories

Apr 15, 2021 04:05PM Praxis Precision Medicines Adds Development Expertise to Board of Directors with Appointment of Jeffrey Chodakewitz, M.D.
Apr 14, 2021 09:07AM Praxis Precision Medicines (PRAX) Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN8A-DEE
Apr 14, 2021 09:00AM Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN8A-DEE
Mar 24, 2021 08:00AM Praxis Precision Medicines to Present at Stifel’s 3rd Annual CNS Day
Mar 17, 2021 07:00AM Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
View More Recent Stories